We are live on
!
Find out more
HKIM
Hayek Kallen Investment Management Portfolio holdings
AUM
$307M
1-Year Est. Return
18.5%
This Fund
S&P 500
This Quarter
Est. Return
+1.23%
1 Year Est. Return
+18.5%
3 Year Est. Return
+68.46%
5 Year Est. Return
+97.89%
10 Year Est. Return
+297.02%
AUM
$140M
AUM Growth
+$849K
(+0.61%)
Cap. Flow
+$268K
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
37.28%
Holding
62
New
2
Increased
25
Reduced
23
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carnival Corporation Ltd
CCL
|
+$416K |
| 2 |
CVS Health
CVS
|
+$274K |
| 3 |
Visa
V
|
+$268K |
| 4 |
AstraZeneca
AZN
|
+$216K |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$179K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$1.07M |
| 2 |
RTX Corp
RTX
|
+$310K |
| 3 |
MRO
Marathon Oil Corporation
MRO
|
+$231K |
| 4 |
Vodafone
VOD
|
+$120K |
| 5 |
CHL
China Mobile Limited
CHL
|
+$104K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.45% |
| 2 | Consumer Staples | 18.66% |
| 3 | Technology | 18.6% |
| 4 | Industrials | 10.62% |
| 5 | Financials | 7.47% |
Similar funds
MWA
ICP
FAM
AC
EWM
ACM
RFM
IPGDR
Hayek Kallen Investment Management's Q3 2016 Portfolio in Review
As of Q3 2016, Hayek Kallen Investment Management held 62 positions worth $140M, up 0.61% from $139M the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Trading was light in Q3 2016: portfolio turnover was 4.8%. Hayek Kallen Investment Management opened 2 new positions and exited 1, leaving the 62-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Staples and Technology.
- Hayek Kallen Investment Management's largest Q3 2016 buy was AstraZeneca: 3,300 shares worth $217K.
- Hayek Kallen Investment Management added most to Carnival Corporation Ltd in Q3 2016, an estimated $416K increase.
- Hayek Kallen Investment Management's biggest Q3 2016 reduction was Thermo Fisher Scientific, cutting an estimated $1.07M.
- Hayek Kallen Investment Management fully exited Marathon Oil Corporation in Q3 2016, selling an estimated $231K.
- Hayek Kallen Investment Management's ten largest holdings make up 37% of its $140M portfolio in Q3 2016.
- Hayek Kallen Investment Management opened 2 new positions and closed 1 in Q3 2016.
- Hayek Kallen Investment Management's portfolio value rose 0.61% quarter-over-quarter to $140M.
Based on Hayek Kallen Investment Management's 13F filing for Q3 2016, filed 20 Oct 2016.